Lars Svensson from Cleveland Clinic: PARTNER Trials Continue to Provide Hope in Cardiovascular Surgery

Since its inception nearly a decade ago the PARTNER trials have shown new opportunities for cardiovascular disease patients to receive treatment they may not have been candidates for before.

Lars Svensson, MD, PhD, from the Cleveland Clinic discussed the latest results from the program, known as PARTNER 2 which was presented during the American College of Cardiology's 65th Annual Scientific Sessions in Chicago. Svensson said the most recent results have shown that not only can patients with severe cardiovascular conditions benefit from the newest surgical options but also those with more moderate health issues.